Does Bravecto Kill Fleas on Cats? | What Vets Prescribe

Yes, Bravecto kills adult fleas on cats and prevents infestations for up to 12 weeks with a single topical dose.

Flea treatments often feel like a monthly chore you can never quite get ahead of — apply, wait a few weeks, then reapply. That rhythm works, but it also means one missed dose can open the door to an infestation.

Bravecto offers a different cadence. It’s a prescription topical that the FDA has approved for 12 weeks of continuous flea protection from one application. Below, we’ll look at how it works, what the research shows, and what cat owners should discuss with their vet before using it.

How Bravecto Kills Fleas on Cats

Bravecto’s active ingredient, fluralaner, belongs to the isoxazoline class of parasiticides. It inhibits GABA-gated chloride channels in fleas and ticks, leading to hyperexcitation and death. This kills adult fleas on the cat.

Applied topically, fluralaner distributes through the skin’s sebaceous glands and releases steadily for weeks. That sustained release is what allows a single dose to control Ctenocephalides felis for 12 weeks.

The product is indicated for both treatment and prevention of flea infestations. In FDA-reviewed laboratory studies, it demonstrated efficacy against existing fleas, so it can clear an active infestation.

Why the 12-Week Window Matters for Cat Owners

Most topical flea preventives require monthly application — 12 doses a year with plenty of opportunities to miss one. Bravecto reduces that to four doses per year, which can simplify flea control significantly.

  • Less handling stress: Applying a topical treatment only four times a year means less wrestling with your cat and less mess for you.
  • Extended tick protection: In addition to fleas, Bravecto kills black-legged ticks and Asian longhorned ticks for 12 weeks, and American dog ticks for 8 weeks.
  • Reduced risk of missed doses: With a 12‑week window, you have a bigger buffer if you forget for a few days compared to monthly products that need strict 30‑day intervals.
  • Veterinary prescription only: Bravecto is not available over the counter; your vet must prescribe it after examining your cat, which ensures it’s appropriate for your pet.

For some cats, quarterly dosing can be a game changer. But it’s only effective if your cat tolerates the application and you follow the schedule. Discuss with your vet whether the 12‑week interval fits your cat’s lifestyle.

The Evidence Behind Bravecto’s Flea Efficacy

The FDA’s original approval for Bravecto (NADA 141‑459) was based on clinical trials that demonstrated its ability to kill adult fleas and prevent infestations for 12 weeks. The product’s label states it is effective against Ctenocephalides felis, the common cat flea.

In those studies, a single topical application provided continuous flea control. The FDA’s review of the data supports the 12‑week duration claim — the FDA approval for flea treatment details the efficacy parameters.

It’s worth noting that Bravecto’s efficacy is against adult fleas only; it does not prevent flea eggs from hatching. However, by killing adult fleas quickly, it can break the flea life cycle over time, especially if you treat all pets in the household.

Feature Detail
Fleas treated Ctenocephalides felis — 12 weeks
Ticks (black‑legged, Asian longhorned) 12 weeks
Ticks (American dog) 8 weeks
Active ingredient Fluralaner (isoxazoline class)
Application Topical, once every 12 weeks
Prescription required Yes

For cat owners who want broader protection, including heartworm and intestinal parasites, Bravecto Plus extends coverage to 8 weeks but adds moxidectin for heartworm prevention.

What Cat Owners Should Know About Bravecto Safety

Like any veterinary medication, Bravecto comes with potential side effects and warnings. The FDA has issued a safety communication about a class of drugs called isoxazoline products, which includes fluralaner. Understanding these risks helps you make an informed decision.

  1. Neurologic adverse events: The FDA warns that cats treated with isoxazoline products may experience muscle tremors, ataxia, or seizures. Cats with a history of seizures or neurologic disorders should not use Bravecto.
  2. Common side effects: In post‑market reports, the most frequently reported adverse events in cats are anorexia, vomiting, and elevated liver enzymes. These are generally mild but should be monitored.
  3. Reporting protocol: If your cat shows any concerning signs after application, contact your veterinarian and consider reporting the event to the FDA Center for Veterinary Medicine.
  4. Veterinary consultation recommended: The FDA advises pet owners to discuss the risks and benefits of isoxazoline products with their vet before starting treatment.

Bravecto has been studied in safety trials, including concurrent use with other medications. Most cats tolerate it well, but individual sensitivities vary. Your vet can help determine if Bravecto is appropriate for your cat’s health history.

Dosing and Administration: The 12‑Week Schedule

Bravecto Topical Solution for Cats is applied as a single dose directly to the skin at the base of the cat’s neck. The bottle should be emptied entirely to ensure the full dose. According to the NLM label, the target dose is minimum 18.2 mg/lb (40 mg/kg) of fluralaner — see the Bravecto dosage every 12 weeks for exact instructions.

After application, the medication is absorbed through the skin and distributed via sebaceous glands. It reaches peak concentrations within a few days and maintains effective levels for 12 weeks. Reapplication is needed at the 12‑week mark to maintain protection.

Bravecto Plus differs: it provides 8 weeks of protection against fleas, ticks, and heartworm. So if you choose the Plus version, you’ll need to apply every 8 weeks. Always confirm the product you’re receiving matches your cat’s needs and your preferred schedule.

Feature Bravecto Bravecto Plus
Flea protection duration 12 weeks 8 weeks
Tick protection duration 12 weeks (some species) or 8 weeks (American dog tick) 8 weeks
Heartworm & intestinal parasite protection No Yes (heartworm, roundworms, hookworms)

The Bottom Line

Bravecto offers a convenient way to protect your cat from fleas for three months with one application. Its active ingredient, fluralaner, is FDA‑approved and supported by clinical trials. However, the FDA also cautions that isoxazoline products can cause neurologic adverse events in some cats, especially those with a seizure history. It’s a trade‑off worth discussing with your veterinarian.

If your cat has any history of seizures, ataxia, or other neurological conditions, your veterinarian can help weigh whether Bravecto’s 12‑week flea protection is the right choice — or whether a different class of flea preventive might be safer.

References & Sources

  • FDA. “Fda Approval for Flea Treatment” Bravecto (fluralaner topical solution) for cats is a prescription medication that kills adult fleas and is indicated for the treatment and prevention of flea infestations caused.
  • NLM. “Bravecto Dosage Every 12 Weeks” Bravecto is administered topically as a single dose every 12 weeks to provide a minimum dose of 18.2 mg/lb (40 mg/kg) of fluralaner.